Our ophthalmology portfolio consists of a full range of eye drops products dedicated to the treatment of patients with several eye diseases such as primary open angle glaucoma the most predominant glaucoma type in the world,1 and ocular surface diseases including dry eye and eye allergy. Timoptol®, Timopotol XE®, and Timoptol® Preservative Free –contains the active ingredient timolol maleate, which is a beta-blocker agent used as anti-glaucoma treatment either in a monotherapy regimen or associated with another anti-glaucoma agent Saflutan® Preservative-Free eye drops that contain the active ingredient tafluprost, which is a prostaglandin analogue, and is used as anti-glaucoma therapy either in a monotherapy regimen or associated with another anti-glaucoma agent Trusopt® and Trusopt® Preservative-Free – eye drops that contain the active ingredient dorzolamide hydrochloride, which is a carbonic anhydrase inhibitor, and is used as anti-glaucoma treatment either in a monotherapy regimen or associated with another anti-glaucoma agent Cosopt® and Cosopt® Preservative-Free– eye drops that contain the fix-dose combination of active ingredient timolol maleate and dorzolamide hydrochloride, which combines a beta-blocker and a carbonic anhydrase inhibitor used as anti-glaucoma agents Betadine® SOOTHING RELIEF DRY & TIRED EYES eye drops that contain Ectoin™ 0.5% preservative free, a natural product to prevent and treat dry eye. Betadine® SOOTHING RELIEF EYE ALLERGY eye drops that contain Ectoin™ 2% preservative free, a natural product to prevent and treat eye allergy. ® Timoptol, Trusopt, Cosopt & Saflutan are registered trademarks of Mundipharma AG in UAE and are either registered trademarks or trademarks in other countries. Please refer to individual countries for full local prescribing information and indications as approved by relative health authorities * Not all products or indications are available in all countries. Products are currently under registrations across Middle East, Turkey and Africa Region and subject to approval according to local laws and regulations. Please refer to your local representative office and the locally approved prescribing information for more details on the product and indications. Furthermore, Mundipharma Middle East FZLLC provides the information for readers from many countries in the ME region as of this date and does not undertake any obligation to update any forward-looking statements contained in this newsletter as a result of new information, future events or otherwise. 1 Quigley et al. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–267.
Ophthalmology
PRODUCT NAME
PRODUCT DESCRIPTION
Trusopt® Ophthalmic Solution
Dorzolamide Hydrochloride 2%
Cosopt® Ophthalmic Solution
Dorzolamide Hydrochloride 20 mg/ml (+)
Timolol Maleate 5 mg/ml
Cosopt PF® Ophthalmic Solution
Dorzolamide Hydrochloride 20 mg/ml (+)
Timolol Maleate 5 mg/ml
Saflutan® Ophthalmic Solution
Tafluprost 15 mcg/ml
Timoptol® 0.50% Ophthalmic Solution
Timolol Maleate 0.50%
Timoptol® XE 0.5% Ophthalmic Solution
Timolol Maleate 0.50%
Betadine® SOOTHING RELIEF DRY & TIRED EYES
Ectoin™ 0.5% preservative free
Betadine® SOOTHING RELIEF EYE ALLERGY
Ectoin™ 2% preservative free
The product range includes:
